Talks and shows

Decoding ageing

Biotechnology expert Carina Kern delves into the science of ageing, and whether we might be able to slow the process down.

Image via Pexels

In this thought-provoking talk, Carina Kern, CEO of LinkGevity and a leading voice in ageing science, will explore the biology behind how we age and the emerging interventions that could transform our healthspan. Carina will introduce us to the Blueprint Theory of ageing, and how the triggered molecular pathways uncovered by the theory have revealed the origins of ageing and age-related disease for the first time.  

From the role of necrosis in cellular decline to AI-driven drug discovery, Carina will unpack the latest research, and challenge the way we think about ageing, resilience, and longevity - both on Earth and for space exploration where degeneration is accelerated. Join us as we explore whether science is on the cusp of unravelling one of life’s greatest mysteries - and what that means for the future of medicine. 

Event type

This is a theatre and livestream event for an adult audience, where the speakers and audience in our Theatre are joined by our audience online. 

By booking to attend events at the Royal Institution, you confirm that you have read and accept the Ri's event terms and conditions. You also agree to abide by our code of conduct, and help to create a great experience for yourself and your fellow participants. Please note that Eventbrite adds a small booking fee to the amount paid for each ticket option.

For any queries regarding this event please get in touch by phone 020 7409 2992 or email events@ri.ac.uk.

About Carina Kern

Image of Carina Kern
Carina Kern

Carina Kern is the Chief Scientific Officer and CEO of LinkGevity, an AI-powered biotech company driving innovation in drug discovery for ageing and resilience loss. 

With a background in Molecular Biology, Pharmacology, Evolutionary Biology, and Genetics, she is renowned for her pioneering work on ageing mechanisms and lifespan extension. Carina developed a new Blueprint Theory of Aging, which takes an integrative approach to understanding aging, combining evolutionary theory, genetics, molecular mechanisms and medicine, and is used to structure LinkGevity's AI. 

Her research has led to the development of a first-in-class necrosis inhibitor targeting cellular degeneration (Anti-Necrotic™). The Anti-Necrotic™ has been selected as one of only 12 global innovations for NASA’s Space-Health program, recognizing its potential to mitigate accelerated aging in astronauts on long-duration space missions.

Timing

Doors to the theatre will open at 6.45pm and the talk will begin at 7.00pm.

Timing for the livestream

The livestream will go live at 6.55pm and the introduction will begin at 7.00pm. If you register but miss the livestream, the video will be available to you via the same link for two weeks after the event date.

Accessibility

The event will take place on the first floor and there is step-free access from the street via lift.

The closest underground station is Green Park, which is step-free.

There is space at floor level in the theatre for wheelchair users.

Seating is usually unreserved for our events. If you and your group require seating reservations, please do let us know by emailing us at events@ri.ac.uk, and we’ll be more than happy to help.

Carers can receive a free ticket to an event by emailing events@ri.ac.uk.

Our theatre is equipped with an Audio Induction Loop. 

Event terms and conditions